• OPEN AN ACCOUNT
Indian Indices
Nifty
25,019.80 -42.30
(-0.17%)
Sensex
82,330.59 -200.15
( -0.24%)
Bank Nifty
55,354.90 -0.70
( 0.00%)
Nifty IT
37,972.35 -321.45
( -0.84%)
Global Indices
Nasdaq
42,674.05 330.30
(0.78%)
Dow Jones
5,978.97 41.04
(0.69%)
Hang Seng
37,763.30 7.79
(0.02%)
Nikkei 225
8,684.56 50.81
(0.59%)
Forex
USD-INR
85.50 0.17
(0.19%)
EUR-INR
95.69 0.13
(0.13%)
GBP-INR
113.61 0.11
(0.10%)
JPY-INR
0.59 0.00
(0.74%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
98.3315118
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
132.14
416272.62
EPS(TTM)
Face Value()
Div & Yield %
13.13
1
0.78
 

India Glycols consolidated net profit rises 51.67% in the March 2025 quarter
May 17,2025
Net profit of India Glycols rose 51.67% to Rs 64.02 crore in the quarter ended March 2025 as against Rs 42.21 crore during the previous quarter ended March 2024. Sales declined 6.79% to Rs 863.22 crore in the quarter ended March 2025 as against Rs 926.14 crore during the previous quarter ended March 2024.

For the full year,net profit rose 33.49% to Rs 230.92 crore in the year ended March 2025 as against Rs 172.99 crore during the previous year ended March 2024. Sales rose 14.40% to Rs 3768.26 crore in the year ended March 2025 as against Rs 3293.97 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales863.22926.14 -7 3768.263293.97 14
OPM %16.9111.29 -13.5612.22 -
PBDT114.3881.64 40 407.52324.08 26
PBT81.7955.60 47 292.32223.31 31
NP64.0242.21 52 230.92172.99 33